Article Versions Notes

Astarita A, Mingrone G, Airale L, Vallelonga F, Covella M, Catarinella C, Cesareo M, Bruno G, Leone D, Giordana C, et al. Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction. Cancers. 2021; 13(7):1631. https://doi.org/10.3390/cancers13071631

Astarita, Anna, Giulia Mingrone, Lorenzo Airale, Fabrizio Vallelonga, Michele Covella, Cinzia Catarinella, Marco Cesareo, Giulia Bruno, Dario Leone, Carlo Giordana, and et al. 2021. "Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction" Cancers 13, no. 7: 1631. https://doi.org/10.3390/cancers13071631

Astarita, A., Mingrone, G., Airale, L., Vallelonga, F., Covella, M., Catarinella, C., Cesareo, M., Bruno, G., Leone, D., Giordana, C., Cetani, G., Salvini, M., Gay, F., Bringhen, S., Rabbia, F., Veglio, F., & Milan, A. (2021). Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction. Cancers, 13(7), 1631. https://doi.org/10.3390/cancers13071631